Legislative Office Building, Room 5200

Hartford, CT 06106 (860) 240-0200




LCO No.: 4403

File Copy No.: 420

Senate Calendar No.: 245

OFA Fiscal Note

State Impact:

Agency Affected


FY 19 $

FY 20 $

Consumer Protection, Dept.

GF - Potential Revenue Gain

See Below

See Below

Note: GF=General Fund

Municipal Impact: None


This amendment strikes the underlying bill and its associated fiscal impact and results in the following impact. The amendment allows telehealth providers to prescribe schedule II and III controlled substances other than an opioid drug through the use of telehealth for treatment of a psychiatric disability or substance use disorder and results in a potential revenue gain to the state.

The Department of Consumer Protection (DCP) is responsible for investigating and monitoring the prescribing of schedule II and III controlled substances and would be able to do so with existing resouces. The amendment also results in a potential revenue gain to the extent that fines are assessed by DCP for non-compliance with schedule II and III prescription drug regulations. The Commissioner of DCP may impose a fine of up to $1,000 per violation.

The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.